Searched for
BIVALIRUDIN
Nod for Aurobindo Pharma to make, market Bivalirudin injectionCiting market reports, the release said the estimated market size of the Bivalirudin injection was USD 101 million for the year ending May ...- Sun Pharma shares surge over 8%; top gainer on Sensex, NiftyThe stock settled the day with a sharp gain of 8.34 per cent at Rs 1,168.50 on the BSE. In intra-day, it rallied 9.4 per cent to Rs 1,180 -...
- Sun Pharma settles Angiomax litigation with The Medicines CompanyUnder the terms of the agreement, the company's subsidiary is entitled to launch its version of generic Angiomax in the US on June 30, 2019.
- Aurobindo Pharma lands in patent litigation cases in USAIndian firm Aurobindo Pharma has been dragged to court by three multi-national drug makers on allegations of patent infringement.
- Dr Reddy's Labs drops over 5 pc on BSEDr Reddy's Laboratories today fell amid media reports that a US drug maker has sued the company for patent infringement.
Load More